Year |
Citation |
Score |
2012 |
Harrington AJ, Yacoubian TA, Slone SR, Caldwell KA, Caldwell GA. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2142-53. PMID 22323726 DOI: 10.1523/Jneurosci.2606-11.2012 |
0.742 |
|
2011 |
Tucci ML, Harrington AJ, Caldwell GA, Caldwell KA. Modeling dopamine neuron degeneration in Caenorhabditis elegans. Methods in Molecular Biology (Clifton, N.J.). 793: 129-48. PMID 21913098 DOI: 10.1007/978-1-61779-328-8_9 |
0.745 |
|
2011 |
Harrington AJ, Knight AL, Caldwell GA, Caldwell KA. Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease. Methods (San Diego, Calif.). 53: 220-5. PMID 21195766 DOI: 10.1016/J.Ymeth.2010.12.036 |
0.706 |
|
2010 |
Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2. PMID 21152247 DOI: 10.1038/Cddis.2009.4 |
0.703 |
|
2010 |
Pivtoraiko VN, Harrington AJ, Mader BJ, Luker AM, Caldwell GA, Caldwell KA, Roth KA, Shacka JJ. Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. Journal of Neurochemistry. 114: 1193-204. PMID 20534000 DOI: 10.1111/J.1471-4159.2010.06838.X |
0.624 |
|
2010 |
Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 1282-95. PMID 20108318 DOI: 10.1002/Dvdy.22231 |
0.691 |
|
2010 |
Ruan Q, Harrington AJ, Caldwell KA, Caldwell GA, Standaert DG. VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease. Neurobiology of Disease. 37: 330-8. PMID 19850127 DOI: 10.1016/J.Nbd.2009.10.011 |
0.758 |
|
2008 |
Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, Caldwell KA. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. Journal of Visualized Experiments : Jove. PMID 19066512 DOI: 10.3791/835 |
0.687 |
|
Show low-probability matches. |